Clinical Trial Update: A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) [Phase 3]

View source ↗

Summary

Phase 3 double-blind study evaluating BMN 110 in Morquio A syndrome (MPS IVA); the trial is completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Iva

Drugs mentioned

• BMN 110

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: MPS IV A | Phase 3 | Status: COMPLETED | Results posted: 2014-04-15